Questionnaires are widely used instruments to monitor gastrointestinal (GI) symptoms. However, few of these questionnaires have been formally evaluated. We sought to evaluate our GI symptoms questionnaire in terms of clarity and reproducibility. Primary care patients referred for open access Helicobacter pylori urea breath testing reported GI symptoms (type+severity) and demographic information by written questionnaire. In an interview, patients gave a personal description of the meaning of the GI symptoms on the questionnaire. Patients' descriptions of GI symptoms were compared with current definitions. Symptom severity scores were compared before and after, interview versus questionnaire. Of the 45 patients included, 19 (42%) described all symptoms correctly, whereas 17 (38%) described one symptom incorrectly. None of the patients made more than three mistakes. Regurgitation was the most common incorrectly described symptom (16 patients [36%]), whereas the other individual symptoms were well explained. Symptom severities before the interview, after the interview and reported by questionnaire (mean value+/-SEM) were 2.1 +/- 0.2, 2.1 +/- 0.2, and 1.5 +/- 0.2 points on a 7-point Likert scale (0-6), respectively. Mean severity reported by interview (95% CI) was 1.4 (1.3-1.5) times higher than reported by questionnaire (P < .05). In conclusion, the GI symptom questionnaire is understandable and has good reproducibility for measuring the presence of GI symptoms, although symptom severity is consistently rated higher when reported by interview.
Calvet X, Bustamante E, Montserrat A, Roqué M, Campo R, Gené E, Brullet E. Calvet X, et al. Eur J Gastroenterol Hepatol. 2000 Aug;12(8):949-53. doi: 10.1097/00042737-200012080-00016. Eur J Gastroenterol Hepatol. 2000. PMID: 10958224
Heading RC, Thomas EC, Sandy P, Smith G, Fass R, Hungin PS. Heading RC, et al. Eur J Gastroenterol Hepatol. 2016 Apr;28(4):455-62. doi: 10.1097/MEG.0000000000000565. Eur J Gastroenterol Hepatol. 2016. PMID: 26735161 Free PMC article.
Carbone F, Vandenberghe A, Holvoet L, Vanuytsel T, Van Oudenhove L, Jones M, Tack J. Carbone F, et al. Aliment Pharmacol Ther. 2016 Nov;44(9):989-1001. doi: 10.1111/apt.13753. Epub 2016 Aug 12. Aliment Pharmacol Ther. 2016. PMID: 27518319 Clinical Trial.
Zhou Q, Li L, Ai Y, Pan Z, Guo M, Han J. Zhou Q, et al. Wien Klin Wochenschr. 2017 Jan;129(1-2):38-45. doi: 10.1007/s00508-016-1117-3. Epub 2016 Nov 15. Wien Klin Wochenschr. 2017. PMID: 27848071 Review.
de Jong JJ, Lantinga MA, Drenth JP. de Jong JJ, et al. World J Gastroenterol. 2019 Jan 14;25(2):178-189. doi: 10.3748/wjg.v25.i2.178. World J Gastroenterol. 2019. PMID: 30670908 Free PMC article. Review.
Bacha AA, Suhail M, Awwad FA, Ismail EAA, Ahmad H. Bacha AA, et al. Front Nutr. 2024 Apr 3;11:1324793. doi: 10.3389/fnut.2024.1324793. eCollection 2024. Front Nutr. 2024. PMID: 38633603 Free PMC article.
Rebello CJ, Boué S, Levy RJ Jr, Puyau R, Beyl RA, Greenway FL, Heiman ML, Keller JN, Reynolds CF 3rd, Kirwan JP. Rebello CJ, et al. Nutrients. 2023 Apr 16;15(8):1920. doi: 10.3390/nu15081920. Nutrients. 2023. PMID: 37111139 Free PMC article. Clinical Trial.
Hamblin H, Gunaratne AW, Clancy A, Pilarinos D, LeBusque A, Dawson MVM, Borody TJ. Hamblin H, et al. Gastroenterol Res Pract. 2022 Oct 13;2022:6083896. doi: 10.1155/2022/6083896. eCollection 2022. Gastroenterol Res Pract. 2022. PMID: 36275423 Free PMC article.
Rasinkangas P, Forssten SD, Marttinen M, Ibarra A, Bothe G, Junnila J, Uebelhack R, Donazzolo Y, Ouwehand AC. Rasinkangas P, et al. Am J Clin Nutr. 2022 Dec 19;116(6):1580-1594. doi: 10.1093/ajcn/nqac264. Am J Clin Nutr. 2022. PMID: 36149331 Free PMC article.
Holscher HD, Chumpitazi BP, Dahl WJ, Fahey GC, Liska DJ, Slavin JL, Verbeke K. Holscher HD, et al. Adv Nutr. 2022 Dec 22;13(6):2084-2097. doi: 10.1093/advances/nmac091. Adv Nutr. 2022. PMID: 36041178 Free PMC article.
